UNLIMITED TURBO SHORT - MERCK & CO. | Market Closed - Euronext Paris 10:00:02 10/05/2024 pm IST | ||
| 3.677 EUR | -1.39% |
|
| Current month | -0.43% | ||
| 1 month | -8.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 3.694 | -0.94% | 72 |
| 09/24/09 | 3.729 | -0.80% | 86 |
| 08/24/08 | 3.759 | -1.98% | 89 |
| 07/24/07 | 3.835 | -4.13% | 89 |
| 06/24/06 | 4 | +2.09% | 81 |
Real-time Euronext Paris
Last update May 10, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| OZ3NB | |
| ISIN | NLBNPNL2NCF8 |
| Date issued | 08/02/2024 |
| Strike | 169 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.9 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.655 € |
|---|---|
| Lowest since issue | 3.445 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1
USD
Average target price
141.6
USD
Spread / Average Target
+8.90%
- Stock Market
- Certificates
- OZ3NB Certificat
